{"title":"原发性甲状腺功能减退患者接受替代治疗后的健康相关生活质量及其与症状评分和甲状腺功能状态的关系","authors":"Merina Martin, Rani Subramaniyan, Dhukhabandu Naik, Lakshmi Ramamoorthy, Hmar T. Lalthanthuami","doi":"10.4103/jfcm.jfcm_103_23","DOIUrl":null,"url":null,"abstract":"BACKGROUND: A number of patients with primary hypothyroidism have reduced health-related quality of life (HR-QoL), even with optimum thyroid hormone replacement therapy. This study aimed to assess the HR-QoL of patients with hypothyroidism under replacement therapy and identify its relationship with the symptom score and thyroid function status. MATERIALS AND METHODS: Using a cross-sectional study design, 175 hypothyroid patients under replacement therapy who visited the Endocrinology Outpatient Department of a tertiary care center were selected by convenient sampling technique. Data was collected using a structured data collection tool comprising, HR-QoL Short Form-36 questionnaire, and Zulewski’s clinical score. Inferential statistical analyses were performed using Mann–Whitney U , Kruskal–Wallis, and Karl–Pearson Correlation tests. RESULTS: The overall mean quality of life score was 44.22 ± 12.14, with a substantial decline in role functioning because of physical health. A significant negative correlation ( P < 0.05) was found between HR-QoL and hypothyroidism symptom score. A significant association was observed between participants’ HR-QoL and their dosage of thyroxine supplement ( P < 0.05,) but no association was found with thyroid function status. CONCLUSION: There was a substantial reduction in the quality of life of the patients despite being on thyroid replacement therapy and achieving euthyroid status. This underlines the importance of symptom reduction and hormone optimization to enhance the quality of life.","PeriodicalId":46862,"journal":{"name":"Journal of Family and Community Medicine","volume":"97 1","pages":"0"},"PeriodicalIF":1.9000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Health-related quality of life and its association with the symptom score and the thyroid function status of patients with primary hypothyroidism on replacement therapy\",\"authors\":\"Merina Martin, Rani Subramaniyan, Dhukhabandu Naik, Lakshmi Ramamoorthy, Hmar T. Lalthanthuami\",\"doi\":\"10.4103/jfcm.jfcm_103_23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND: A number of patients with primary hypothyroidism have reduced health-related quality of life (HR-QoL), even with optimum thyroid hormone replacement therapy. This study aimed to assess the HR-QoL of patients with hypothyroidism under replacement therapy and identify its relationship with the symptom score and thyroid function status. MATERIALS AND METHODS: Using a cross-sectional study design, 175 hypothyroid patients under replacement therapy who visited the Endocrinology Outpatient Department of a tertiary care center were selected by convenient sampling technique. Data was collected using a structured data collection tool comprising, HR-QoL Short Form-36 questionnaire, and Zulewski’s clinical score. Inferential statistical analyses were performed using Mann–Whitney U , Kruskal–Wallis, and Karl–Pearson Correlation tests. RESULTS: The overall mean quality of life score was 44.22 ± 12.14, with a substantial decline in role functioning because of physical health. A significant negative correlation ( P < 0.05) was found between HR-QoL and hypothyroidism symptom score. A significant association was observed between participants’ HR-QoL and their dosage of thyroxine supplement ( P < 0.05,) but no association was found with thyroid function status. CONCLUSION: There was a substantial reduction in the quality of life of the patients despite being on thyroid replacement therapy and achieving euthyroid status. This underlines the importance of symptom reduction and hormone optimization to enhance the quality of life.\",\"PeriodicalId\":46862,\"journal\":{\"name\":\"Journal of Family and Community Medicine\",\"volume\":\"97 1\",\"pages\":\"0\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Family and Community Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jfcm.jfcm_103_23\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Family and Community Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jfcm.jfcm_103_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
摘要
背景:许多原发性甲状腺功能减退患者的健康相关生活质量(HR-QoL)下降,即使采用最佳甲状腺激素替代治疗。本研究旨在评估甲状腺功能减退患者在替代治疗下的HR-QoL,并确定其与症状评分和甲状腺功能状态的关系。材料和方法:采用横断面研究设计,采用方便抽样技术选择175例甲状腺功能减退患者,这些患者在三级保健中心内分泌门诊接受替代治疗。使用结构化数据收集工具收集数据,包括HR-QoL Short Form-36问卷和Zulewski临床评分。采用Mann-Whitney U、Kruskal-Wallis和Karl-Pearson相关检验进行推理统计分析。结果:患者总体平均生活质量评分为44.22±12.14,由于身体健康原因,角色功能明显下降。显著负相关(P <HR-QoL与甲状腺功能减退症状评分之间差异无统计学意义(0.05)。观察到参与者的HR-QoL与甲状腺素补充剂量之间存在显著相关(P <0.05,),但与甲状腺功能状态无相关性。结论:尽管接受甲状腺替代治疗并达到甲状腺功能正常状态,患者的生活质量仍有明显下降。这强调了减轻症状和优化激素以提高生活质量的重要性。
Health-related quality of life and its association with the symptom score and the thyroid function status of patients with primary hypothyroidism on replacement therapy
BACKGROUND: A number of patients with primary hypothyroidism have reduced health-related quality of life (HR-QoL), even with optimum thyroid hormone replacement therapy. This study aimed to assess the HR-QoL of patients with hypothyroidism under replacement therapy and identify its relationship with the symptom score and thyroid function status. MATERIALS AND METHODS: Using a cross-sectional study design, 175 hypothyroid patients under replacement therapy who visited the Endocrinology Outpatient Department of a tertiary care center were selected by convenient sampling technique. Data was collected using a structured data collection tool comprising, HR-QoL Short Form-36 questionnaire, and Zulewski’s clinical score. Inferential statistical analyses were performed using Mann–Whitney U , Kruskal–Wallis, and Karl–Pearson Correlation tests. RESULTS: The overall mean quality of life score was 44.22 ± 12.14, with a substantial decline in role functioning because of physical health. A significant negative correlation ( P < 0.05) was found between HR-QoL and hypothyroidism symptom score. A significant association was observed between participants’ HR-QoL and their dosage of thyroxine supplement ( P < 0.05,) but no association was found with thyroid function status. CONCLUSION: There was a substantial reduction in the quality of life of the patients despite being on thyroid replacement therapy and achieving euthyroid status. This underlines the importance of symptom reduction and hormone optimization to enhance the quality of life.